EDIT Snapshot | |
---|---|
Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. The company is headquartered in Cambridge, Massachusetts. | |
VALUATION DATA | |
Market Capitalization | $605,831,000 | Price to Sales | 9.00 |
Earnings per Share | $-2.0200 |
PE Ratio | None |
PRICE DATA | |
Most Recent Close | $7.4200 |
52 Week High | $7.81 |
52 Week Low | $1.692 |
50-Day Moving Average | $3.893 |
200-Day Moving Average | $-1.864 |
All data are from Alpha Vantage as of today. For more infomation on EDIT see Stock Dividend, Valuation, Price and Financial Data for Investors |